Thiostrepton Analogues via Cobalt-Catalyzed C-H Amidation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Thiostrepton, a potent antibiotic against Gram-positive bacteria, is not clinically used due to its low aqueous solubility, and developing analogues with improved solubility and antibacterial activity is challenging due to its structural complexity and reactivity, limiting the synthesis of effective thiostrepton analogues.

Innovation Solution

The development of thiostrepton analogues through cobalt-catalyzed C—H amidation, which introduces amide linkages while maintaining the dehydroamino acid structure, enhancing aqueous solubility and antibacterial activity without affecting the delicate functional groups of thiostrepton.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If thiostrepton is used as an antibiotic, then potent antibacterial activity is achieved, but low aqueous solubility prevents clinical use

Engineering Contradiction:
Improveantibacterial activityVSAvoidaqueous solubility
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent modifies the chemical structure of thiostrepton by introducing polar amide groups through C-H amidation reactions. This changes the molecular parameters (increasing polarity and hydrogen bonding capacity) to improve aqueous solubility while preserving the core macrocyclic structure responsible for antibacterial activity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates hybrid molecules combining the thiostrepton core structure with amide-containing side chains. These composite structures integrate the hydrophobic macrocyclic domain (for biological activity) with hydrophilic amide domains (for solubility), resolving the solubility-activity contradiction

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If total synthesis is used to prepare thiostrepton analogues, then structural modifications are possible, but high structural complexity makes it unrealistic

Engineering Contradiction:
Improveanalogue developmentVSAvoidstructural complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent divides the synthesis into two segments: (1) biosynthetic production of the complex thiostrepton core by Streptomyces bacteria, and (2) subsequent chemical modification of specific C-H bonds. This segmentation allows the complex core to be prepared once, with simpler follow-up modifications for analogue development

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses cobalt catalysts as intermediaries to enable C-H amidation reactions. These catalysts mediate the transformation of inert C-H bonds into reactive sites for amide formation, allowing structural modifications without requiring complex total synthesis routes

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If fermentation is used to generate thiostrepton in large quantities, then quantity is improved, but reactive functionalities and degradation propensity constrain the methods

Engineering Contradiction:
Improveproduction quantityVSAvoidchemical stability
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The patent performs C-H amidation modifications immediately after fermentation while the thiostrepton is still in a relatively stable state. By conducting reactions under controlled conditions with appropriate catalysts and reagents, the method prevents degradation that would occur with prolonged storage or harsh processing

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs inert or controlled reaction environments during the C-H amidation process to protect the reactive functionalities of thiostrepton from degradation. This includes using anhydrous conditions, inert solvents, and controlled atmospheres to maintain chemical stability during modification

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

4Ease of manufacture

If chemical modification is performed on thiostrepton, then aqueous solubility is improved, but delicate functional groups must not be affected

Engineering Contradiction:
Improveaqueous solubilityVSAvoidfunctional group integrity
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent applies C-H amidation at specific localized positions on the thiostrepton molecule rather than globally modifying all functional groups. The cobalt catalyst selectively activates particular C-H bonds (such as those at C2' and C3' positions), allowing solubility improvement while leaving other delicate functional groups intact

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent replaces traditional chemical modification approaches (which might affect multiple functional groups) with cobalt-catalyzed C-H activation. This catalytic mechanism selectively targets C-H bonds through coordination chemistry rather than aggressive chemical reagents, preserving the integrity of other functional groups

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the production of thiostrepton analogues with improved aqueous solubility and retained antibacterial activity, facilitating their use in treating bacterial infections effectively.

Implementation Method 1

The development of thiostrepton analogues through cobalt-catalyzed C—H amidation, which introduces amide linkages while maintaining the dehydroamino acid structure

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS20220315624A1Thiostrepton analogs and methods of making and using same
Publication Date: 2022.10.06 YALE UNIVERSITY
  • US20220315624A1 patent drawing
  • US20220315624A1 patent drawing
  • US20220315624A1 patent drawing

AI summary

Provided herein are thiostrepton analogues, such as but not limited to compounds of Formula I, with improved aqueous solubility and antibacterial properties against antibiotic-resistant bacterial strains. The methods of the disclosure further provide a chemoselective way to introduce diverse functionality into peptides or protein comprising a dehydroalanine residue.